Sign In
Free Newsletter
Dr. Reddy’s to pay $633M for Haleon’s nicotine replacement business
The planned acquisition of the external U.S. unit expands the buyer's over-the-counter offerings amid a push to make the consumer health sector a key focus area for investments.
Dr. Reddy’s promotes 18-year exec to lead North America business
In his most recent role as chief commercial officer, Milan Kalawadia was "instrumental in driving North America to three consecutive years of growth over the $1 billion revenue threshold and achieving record sales in FY24,” said company CEO Erez Israeli.
Experts explore changing nature of the workplace
A panel featuring professionals from NRS Inc., Dr. Reddy’s Laboratories Inc. and Growth Potential Consulting dove into topics such as new models of working, navigating how to call employees back to the office, ways to attract and hold onto talent, the adoption of AI and much more.
